Dahlen, Torsten
54  results:
Search for persons X
?
3

Agnostic studies in epidemiology:

Dahlén, Torsten
I. Dahlén T., Clements M, Zhao J, Olsson M L, Edgren G. An agnostic study of associations between ABO and RhD blood group and phenome-wide disease risk. Elife. 10, e65658 (2021). ::doi::10.7554/eLife.65658 ::pmid::33902814 ::isi::000656072900001.  , 2023
 
?
6

Adverse outcomes in chronic myeloid leukemia patients treat..:

Dahlén, Torsten ; Edgren, Gustaf ; Ljungman, Per...
American Journal of Hematology, 0361-8609, 2022, 97:4, s. 421-430.  , 2022
 
?
9

Adverse outcomes in chronic myeloid leukemia patients treat..:

Dahlén, Torsten ; Edgren, Gustaf ; Ljungman, Per...
American Journal of Hematology, 0361-8609, 2022, 97:4, s. 421-430.  , 2022
 
?
10

Adverse outcomes in chronic myeloid leukemia patients treat..:

Dahlen, Torsten ; Edgren, Gustaf ; Ljungman, Per...
American Journal of Hematology, 0361-8609, 2022, 97:4, s. 421-430.  , 2022
 
?
12

Successful tyrosine kinase inhibitor discontinuation outsid..:

Flygt, Hjalmar ; Sandin, Fredrik ; Dahlén, Torsten...
British Journal of Haematology, 0007-1048, 2021, 193:5, s. 915-921.  , 2021
 
?
13

Successful tyrosine kinase inhibitor discontinuation outsid..:

Flygt, Hjalmar ; Sandin, Fredrik ; Dahlen, Torsten...
British Journal of Haematology, 0007-1048, 2021, 193:5, s. 915-921.  , 2021
 
?
14

Successful tyrosine kinase inhibitor discontinuation outsid..:

Flygt, Hjalmar ; Sandin, Fredrik ; Dahlén, Torsten...
British Journal of Haematology, 0007-1048, 2021, 193:5, s. 915-921.  , 2021
 
1-15